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Research Area Research Need
Basic Research Dissection ofdirect immune-endocrine interactions
Understanding of cellular and molecular mechanisms
Sensitive, inexpensive, and widely available analytical tools
Understanding the biological significance of subtle low-dose effects
Identify and characterize critical windows ofsusceptibility across species
Characterize source of population heterogeneity in dose responsiveness
(age, gender, nutrition, etc.)
Exposure Determination Rapid andinexpensive Xposure moitorng ithodsforuse inwildlf
populatns
Increased moniong efots to id if statsndtrends Of
EDs
Environmental causes ofliver, brain, and lung cancers
Mixtures Research to address the additivity principle for mixtures
In vitro and in vivostudies of complex mixtures to evaluate validity ofTEQs
Identification andtesting ofenvironmentally relevant mixtures
Systematic evaluation ofspecies, cellular, and age dependent response to
mixtures of EDs
MultidisciplinaryStudies Systematicfieldandlabortorystudiesfbcused on criticaluncettainies
Examination ofcorrelaonofefts tiewildlif andmammian
models
Multidisciplinary studies on effectsofeidocrine disrupio
Examinato ofmuliple endpoin n mtip t o ED ao
Risk Models Statistical models to predict riskfrom exposure and effects
Improvements in study design
Evaluation oftoxicity and mechanistic endpoints across species
Toxicokinetics and toxicodynamic studies ofenvironmentally relevant
chemicals
Quantitative dose response models based upon receptor
theory/biochemical interactions
Establishmentoftraining programs in biomatheticsfor BBDRmodel
construction
Source: Adapted from Kavlock RJ et al., Research needs for the risk assessment of health and environ-
mental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. Environ Health
Perspect, 104(Suppl 41:715-740 (1996).
"Although trends in hormonally related
diseases have not been clearly linked to
environmental chemicals, it is probable that
endocrine disruptors are contributing to
human diseases and dysfunction. The ques-
tion then becomes how much they are con-
tributing," Lucier said. "What is needed is
high-quality basic and applied research to
examine a number ofcritical areas."
Many individual federal agencies have
been working to develop research needs
and priorities. In April 1995, the EPA
sponsored an interdisciplinary workshop
on the human health and ecological effects
ofendocrine disruptors to identify research
gaps and determine future research priori-
ties. According to the workshop summary,
attendees concluded that research should
focus primarily on effects on development
of reproductive capability, on improved
exposure assessment, and on the effects of
mixtures. (See conference summary report,
Environmental Health Perspectives, August
1996.)
The goal of the CENR working group
is to evaluate and harmonize the needs and
priorities of the various agencies. Lucier
says that an interagency approach is impor-
tant to the development ofa national strat-
egy. "The most effective way to utilize basic
research to make sound policy decisions is
to develop interagency approaches that
maximize its application to multiple agen-
cies," he said. "We will develop cross-cut-
ting approaches useful










ing to a preliminary
draft of the strategy,





the reproductive system. Other priorities
include assessing the potential carcinogenic
effects and the toxicology of mixtures and
assessing the nature and extent of contami-
nation in the area ofexposure. The group is
also working to develop a comprehensive
evaluation of all federally funded research
projects on endocrine disruptors. According
to Lucier, the group will also focus on how
to link scientific activities to public policy
decisions. The strategy is due out in
September.
Rewarding Cancer Research
Alfred G. Knudson, Jr., and Joseph F.
Fraumeni are this year's recipients of the
Irving J. Selikoff Award for Cancer
Research. Knudson and Fraumeni earned
the award specifically for "research on the
molecular origins ofcancer and its applica-
tion to the management of populations at
high risk," said Sheldon Samuels, vice pres-
ident for policy studies at the Ramazzini
Institute, which was founded by Selikoffto
promote occupational and environmental
health research. The Ramazzini Institute
sponsors the annual award.
Selikoff, who died in 1992, is remem-
bered for his work at NewYork's Mt. Sinai
School of Medicine in linking cancer and
other diseases with environmental pollu-
tants such as asbestos. The award consists
of a plaque and a monetary prize given
from a fund developed by Selikoff at the
Ramazzini Institute. "We decided to keep
the fund alive," Samuels said, adding that
the fund is entirely privately endowed. The
award is given to scientists who demon-
strate excellence in expanding genetic
research on how to repair cancer-causing
damage-to prevent cancer from later
appearing even though people have been
exposed in the past. The award recipients
are selected by a panel of officers at the
Ramazzini Institute.
Selikoff standouts. Alfred 6. Knudson, Jr. and Joseph F. Fraumeni (left to
right holding boxes) are the 1996 winners of the Irving J. Selikoff Award for
Cancer Research. They are flanked by Philip Landrigan (left) and Arthur C.
Upton (right) ofthe Mt. Sinai School of Medicine.
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Knudson, a researcher at the Fox
Chase Cancer Center in Philadelphia,
Pennsylvania, was chosen for his research
on developing models of carcinogenesis.
"He is not only a great laboratory scientist,
but he happens to be a conceptualizer, a
theoretical biologist whose models of car-
cinogenesis are the basis of much of the
research on the interface between the envi-
ronment and our genetic inheritance,"
Samuels said. "Knudson was one of the
conceptual pioneers who discovered the
family of genes associated with retinal
glaucoma, which is important in under-
standing cancer in general, because this
same family is important in other cancers.
Fraumeni, who is director of the
Division of Cancer Epidemiology and
Genetics at the National Cancer Institute
(NCI) in Bethesda, Maryland, was given
the award for his research in environmen-
tal and genetic factors in cancer, and in
clarifying the role ofgenetic susceptibility.
According to Samuels, one of
Fraumeni's most significant accomplish-
ments has been the development ofa pro-
gram at the NCI in genetics and epidemi-
ology. The program, links molecular biol-
ogy, epidemiology, and prevention. "We
are just now beginning to see the fruits of
[Fraumeni's] work," Samuels said. "He
deserves to be recognized for his achieve-
ment in pulling that program through."
The awards were presented 21 May 1996
at the Mt. Sinai School ofMedicine. "It's
a great honor," said Fraumeni. "Both Dr.
Knudson and I were delighted to receive
the award given in memory of Dr.
Selikoff, who contributed so much to the
area ofenvironmental cancer research.
New Evidence on Sperm
Counts
In 1992, a Danish research team led by
Niels Skakkebaek at the National
University Hospital in Copenhagen pub-
lished in the British MedicalJournal the
results of a meta-analysis of sperm count
studies covering 50 years. The team con-
cluded that human sperm counts had
declined by as much as 50% during that
time. Since then, many environmentalists,
journalists, and reputable scientists have
relied on this study to assert that environ-
mental toxins are having an adverse effect
on male fertility. Of special concern are
both natural and manmade compounds
called endocrine disruptors.
Three reports in the May 1996 issue of
Fertility and Sterility challenge the asser-
tion that sperm counts are declining
worldwide. Sperm quality is measured by
Food, Drugs, and More
One-fourth ofthe money spent each year byAmericans is spent on products regulated
by the U.S. Food and Drug Administration; this amounts to over $1 trillion worth of
goods-from eyeshadow to AZT-that must meet FDA guidelines for product safety
andquality. Currently, all foods anddrugs (forboth animals andpeople), cosmetics, and
radiation-emitting equipment are FDA regulated, and the agency seems poised to add
the $2.8 billion tobacco industry to this list. From proposing tobacco regulation to
researching the effects ofthe "morning after" pill, this obligation requires that the FDA
study and debate some ofthe most divisive issues facing the nation. Part ofthe continu-
ingdialogue between the FDA and the public consists ofthe agency's home page, locat-
ed at http://www.fda.gov/fdahomepage.html, the entranceway to a well-designed
resource on FDAprograms andregulations.
From the home page, a user can choose one ofeight icons to link to the home pages
ofspecific FDA programs, read the FDA news, or change to another directory. Despite
the aesthetic appeal otthesite, however, thecom-
plex structure ofthe FDAcan make itdifficult to
find the particular information beingsought. The
FDA search engine, which can be accessed from
the bottom ofthe home page, offers anotherway
to find FDAdocuments onspecific subjects.Also
located on the home page is a Comments link
-, ~I
thatallows users to correspondwith theFDAviaelectronic mail.
Through the FDANews linkX users can find information such as the text ofproposed
tobacco regulations andguidelines forprotecting children fromleadpoisoning. Theresults
ofrecentresearch studies arealsopresented herealongwithcurrentpress releasesandprod-
uct recalls (underthe Latest FDAEnforcement Reportlink). Thissite also offersacalendar
ofupcomn meetings andsymposia and asearchable archive ofpast press rels, papers,
testimonies, reports, artides, and majorspeeches. Another linkbrings up the latest issue of
FDA Consumernmagane, with full textofartides andbackissues.
The Foods icon links users to information from the Center for Food Safety and
Applied Nutrition, along with external biology-related resources that can be accessed
from the CFSAN page via the Info link. Other links connect users to consumer advice
on food handling, information on food additives like olestra and MSG, and fcts about
foodborne illnesses. The Bad Bug Book, which can be found under the Foodborne
Illness link, provides descriptions ofcommon pathogens as well as information about
disease outbreaks andsymptoms.
The Center for Drug Evaluation and Research site, linked through the Human
Drugs icon, is evolving into a comprehensive resource on drug composition and regula-
tion. Information on how the FDA screens new drugs, approves them for market, and
ensures accuracy in testing, formulation, and labeling can be reached from the CDER
home page by selecting theAbout CDER icon and following the Office ofCompliance
link to theAnnual Report FY 95. Also vithin the annual report are pages on FDAdrug
recalls and adirectorythatlists FDApersonnel bytheirareaofexpertise. TheDivision of
Over-the-Counter Drug Products maintains lists ofdrug name changes and will soon
host a complete database ofactive drug ingredients. The Drug Info icon on the CDER
home page brings users to a list ofapproved drug products with therapeutic equivalence
evaluations along with descriptions ofdrugs that have been approved in the last three
years. Guidance documents for the drug nu ring industry can be reached from
the CDERhome page viatheRegulatoryGuidance link.
The links to other FDA programs-Biologics, Devices and Radiological Health,
Animal Drugs, Cosmetics, Field Operations and Imports, and Toxicology-all provide
datapertinent to thoseparticularfields. Forinsance, the CenterforBiologics Evaluation
and Research (Biolo i lnk), which oversees the manufacture and sale ofvaccines and
bloodproducts, provides a link to the Vaccine Adverse Response Reporting System. The
Center for Devices and Radiological Health provides a useful list ofsafety alerts and
advisories under the Program Areas link, and the National Center for Toxicological
Research can bereachedthrough theToxicology icon.
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